| Value | ₹250.0 Cr |
|---|
BSE filing, NSE: VOEPL. Summary written from the filing by ALFA Finder's alert engine.
Virtuoso Optoelectronics Ltd: key numbers
- Share price
- ₹459.80
- Market cap
- ₹1,653 Cr
- Revenue (annual)
- ₹823.6 Cr
- Net profit (annual)
- ₹15.03 Cr
- P/E (TTM)
- 93.5×Sector 40.5×
- Promoter holding
- 44.05%-5.69% QoQ
- FII holding
- 16.69%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Virtuoso Optoelectronics Ltd
All →Virtuoso Optoelectronics Board Meeting Date
Virtuoso Optoelectronics scheduled its board meeting for November 6, 2026, to approve Q1 and H1 FY27 unaudited financial results. Trading window stays closed until 48 hours post-declaration.
Virtuoso Optoelectronics Other Announcement
Virtuoso Optoelectronics Ltd filed its quarterly shareholding pattern for the period ending October 2026. This periodic disclosure provides details on promoter and public equity holdings.
Virtuoso Optoelectronics Preferential Issue
Virtuoso Optoelectronics allotted 16,89,859 equity shares in a preferential issue to three investors on 15 Oct 2026. Paid-up capital rose from ₹34.25 Cr to ₹35.94 Cr, reflecting ₹1.69 Cr of new capital.
- Value
- ₹1.69 Cr
Virtuoso Optoelectronics Preferential Issue
Virtuoso Optoelectronics allotted 16,89,859 equity shares at ₹503 each to three non-promoter funds, raising ₹85 Crore. This completes the preferential issue approved at the September 2026 EGM.
- Value
- ₹85.00 Cr
Virtuoso Optoelectronics Other Announcement
Virtuoso Optoelectronics Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026. This is a routine regulatory compliance filing.
Virtuoso Optoelectronics Partnership
Virtuoso Optoelectronics signed a non-binding MOU with the Government of Maharashtra for a proposed investment in manufacturing capacity, planned over five years.
- From
- Government of Maharashtra
- Execution
- 5 years
Other fund raise announcements
All →Sudarshan Pharma Industries Fund Raise of ₹72 Cr
Sudarshan Pharma's board approved up to Rs. 72 Crore of preferential convertible warrants for promoters Hemal and Sachin Mehta. Shareholder approval will be sought at an EGM.
- Value
- ₹72.00 Cr
Flywings Simulator Training Centre Fund Raise of ₹68.2 Cr
Flywings Simulator's board approved Rs. 68.20 Crore fully convertible warrants on a preferential basis. Promoter Rupal Mandavia is allotted Rs. 25 Crore, subject to shareholder approval.
- Value
- ₹68.20 Cr
Kanel Industries Fund Raise of ₹16.99 Cr
Kanel Industries' board approved a rights issue of 42.52 lakh equity shares at Rs.39.95 each. The issue aggregates about Rs.16.99 Crore, with record date 13 November 2026.
- Value
- ₹16.99 Cr
- Execution
- Rights issue opens 23 November 2026 and closes 30 November 2026
Sudarshan Pharma Industries Fund Raise
Board approved issuing up to 72 Crore warrants to promoters on a preferential basis. Pricing per Reg 164 is pending, with no fixed rupee value stated.
GAIL (India) Fund Raise
GAIL Board approved in principle the IPO of subsidiary GAIL Gas Limited on Indian exchanges. GAIL will dilute its GGL equity up to 25%.
Gujarat Inject (Kerala) Fund Raise of ₹3 Cr
Gujarat Inject Kerala's board approved a Rs.3 Crore preferential warrant issue to public investors. Authorised capital will rise to Rs.17.63 Crore, subject to shareholder approval.
- Value
- ₹3.00 Cr